factory supply GMP,DMF Levetiracetam CAS NO.102767-28-2

We are very compeitive on Levetiracetam.Our mfr is GMP certified for this item with CEP document.

Product Name:	Levetiracetam
CAS:	102767-28-2
MF:	C8H14N2O2
MW:	170.20896
EINECS:	600-348-9
Product Categories:	Other APIs;Pharmaceutical raw material;Amines;Chiral Reagents;Heterocycles;API;Anticonvulsant;Intermediates & Fine Chemicals;Pharmaceuticals;Miscellaneous Compounds;Nootropic;Smart drug;pharmaceutical intermdiate
Mol File:	102767-28-2.mol

Description	Levetiracetam is a third-generation antiepileptic drug known in the UK and USA.
Generic formulation	MHRA/ CHM advice to minimize risk when switching patients with epilepsy between different manufacturers’ products (including generic products): It is usually unnecessary to ensure that patients are maintained on a specific manufacturer’s product unless there are specific concerns, such as patient anxiety and risk of confusion/ dosing error.
Indications	Epilepsy: monotherapy (not approved in USA) and adjunctive therapy of focal seizures with or without secondary generalization. Recommendations summarized from NICE (2012) Seizure types: first line (myoclonic seizures, focal seizures), adjunctive (generalized tonic- clonic seizures, myoclonic seizures, focal seizures), on referral to tertiary care (absence seizures). Epilepsy types: first line (juvenile myoclonic epilepsy, benign epilepsy with centrotemporal spikes, Panayiotopoulos syndrome, late-onset childhood occipital epilepsy), adjunctive (juvenile myoclonic epilepsy, epilepsy with generalized tonic- clonic seizures only, idiopathic generalized epilepsy, benign epilepsy with centrotemporal spikes, Panayiotopoulos syndrome, late- onset childhood occipital epilepsy).